Members of the billionaire Sackler family that own Purdue Pharma LP have agreed to a bigger opioid settlement with the handful of states that worked to overturn its prior deal.
The family has struck a deal worth as much as $6 billion with the dissenting states, a court-appointed mediator said in a report Thursday. Under the agreement, those states will drop their ongoing appeal of the previous iteration of Purdue’s plan.
The agreement eases Purdue’s path toward resolving trillions of dollars claims by state and local governments over the company’s role in the opioid crisis. It will also give Sackler family members broad immunity from future opioid lawsuits.
